Dr. Sani Kizilbash, MD, MPH
Claim this profileMayo Clinic in Rochester
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
22 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MET positive
EGFR positive
2Brain Tumor
Stage IV
IDH negative
Stage III
Affiliated Hospitals
Clinical Trials Sani Kizilbash, MD, MPH is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
EGFR Inhibitor
for Brain Cancer
This trial is testing a new drug called WSD0922-FU for patients with aggressive brain and spinal cord cancers. The drug works by blocking a protein that helps cancer cells grow. The goal is to find the best dose and see if it can effectively treat these hard-to-treat cancers.
Recruiting1 award Phase 16 criteria
More about Sani Kizilbash, MD, MPH
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sani Kizilbash, MD, MPH has experience with
- Lomustine
- Ipilimumab
- Nivolumab
- Temozolomide
- NMS-03305293 + TMZ
- ELU001
Breakdown of trials Sani Kizilbash, MD, MPH has run
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sani Kizilbash, MD, MPH specialize in?
Sani Kizilbash, MD, MPH focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Sani Kizilbash, MD, MPH currently recruiting for clinical trials?
Yes, Sani Kizilbash, MD, MPH is currently recruiting for 6 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Sani Kizilbash, MD, MPH has studied deeply?
Yes, Sani Kizilbash, MD, MPH has studied treatments such as Lomustine, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Sani Kizilbash, MD, MPH?
Apply for one of the trials that Sani Kizilbash, MD, MPH is conducting.
What is the office address of Sani Kizilbash, MD, MPH?
The office of Sani Kizilbash, MD, MPH is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.